Evidence map›Paper›PMID 28084650›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2017

A Large Inversion Involving GNAS Exon A/B and All Exons Encoding Gsα Is Associated With Autosomal Dominant Pseudohypoparathyroidism Type Ib (PHP1B).

Giedre Grigelioniene, Pasi I Nevalainen, Monica Reyes, Susanne Thiele, Olta Tafaj, Angelo Molinaro, Rieko Takatani, Marja Ala-Houhala, Daniel Nilsson, Jesper Eisfeldt and 4 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Bidirectional disruption ofProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Molecular Definition of Pseudohypoparathyroidism Variants.The Journal of clinical endocrinology and metabolism · 2021
    Review
  13. Review
  14. Article
  15. A Novel GNAS Duplication Associated With Loss-of-Methylation Restricted to Exon A/B Causes Pseudohypoparathyroidism Type Ib (PHP1B).Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. A New Multisystem Disorder Caused by the Gαs Mutation p.F376V.The Journal of clinical endocrinology and metabolism · 2019
    Article
  20. Pseudohypoparathyroidism.Endocrinology and metabolism clinics of North America · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 6 countries.

Giedre GrigelionieneEndocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Pasi I NevalainenEndocrine Unit, Department of Internal Medicine, Tampere University Hospital, Tampere, Finland.
Monica ReyesEndocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Susanne ThieleEndocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Olta TafajEndocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Angelo MolinaroEndocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Rieko TakataniEndocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Marja Ala-HouhalaDepartment of Pediatrics, Tampere University Hospital, Tampere, Finland.
Daniel NilssonDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Jesper EisfeldtDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Anna LindstrandDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Marie-Laure KottlerCentre Hospitalier Universitaire de Caen, Department of Genetics, Reference Centre for Rare Disorders of Calcium and Phosphorus Metabolism, Caen, France.
Outi MäkitieChildren's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Harald JüppnerEndocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Harvard University · USMassachusetts General Hospital · USVitenparken · NOCentre Hospitalier Universitaire de Caen · FRTampere University · FITampere University Hospital · FIUniversity of Helsinki · FI

Funding

Tissue Phenotyping CoreP01DK011794 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI MANNSTADT, MICHAEL · 1986 to 2023
$44.4M
PTH/PTHRP RECEPTOR DEFECTS IN PSEUDOHYPOPARATHYROIDISMR01DK046718 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI JUEPPNER, HARALD W. · 1993 to 2024
$6.0M
NIDDK NIH HHS P01 DK011794NIDDK NIH HHS R01 DK046718
6 · The paper itself

Abstract

Pseudohypoparathyroidism type Ib (PHP1B) is characterized primarily by resistance to parathyroid hormone (PTH) and thus hypocalcemia and hyperphosphatemia, in most cases without evidence for Albright hereditary osteodystrophy (AHO). PHP1B is associated with epigenetic changes at one or several differentially-methylated regions (DMRs) within GNAS, which encodes the α-subunit of the stimulatory G protein (Gsα) and splice variants thereof. Heterozygous, maternally inherited STX16 or GNAS deletions leading to isolated loss-of-methylation (LOM) at exon A/B alone or at all maternal DMRs are the cause of autosomal dominant PHP1B (AD-PHP1B). In this study, we analyzed three affected individuals, the female proband and her two sons. All three revealed isolated LOM at GNAS exon A/B, whereas the proband's healthy maternal grandmother and uncle showed normal methylation at this locus. Haplotype analysis was consistent with linkage to the STX16/GNAS region, yet no deletion could be identified. Whole-genome sequencing of one of the patients revealed a large heterozygous inversion (1,882,433 bp). The centromeric breakpoint of the inversion is located 7,225 bp downstream of GNAS exon XL, but its DMR showed no methylation abnormality, raising the possibility that the inversion disrupts a regulatory element required only for establishing or maintaining exon A/B methylation. Because our three patients presented phenotypes consistent with PHP1B, and not with PHP1A, the Gsα promoter is probably unaffected by the inversion. Our findings expand the spectrum of genetic mutations that lead to LOM at exon A/B alone and thus biallelic expression of the transcript derived from this alternative first GNAS exon. © 2017 American Society for Bone and Mineral Research.

Indexed as

Chromosome InversionExonsGenes, DominantHeterozygoteAdultChildChild, PreschoolChromograninsChromosome DisordersFemaleGTP-Binding Protein alpha Subunits, GsHumansMalePseudohypoparathyroidismSyntaxin 16ChromograninsGNAS protein, humanGTP-Binding Protein alpha Subunits, GsSTX16 protein, humanSyntaxin 16DISORDERS OF CALCIUM/PHOSPHATE METABOLISMEPIGENETICSGNASG proteinPARATHYROID-RELATED DISORDERS

Identifiers

PMID28084650
PMCPMC5395346
OpenAlexW2577382730

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.